A Randomized, Open Label Trial of Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified.
Phase of Trial: Phase IV
Latest Information Update: 04 Oct 2019
Price : $35 *
At a glance
- Drugs Olanzapine (Primary) ; Lithium
- Indications Bipolar depression; Bipolar II disorders
- Focus Therapeutic Use
- Acronyms OL study
- 27 Mar 2019 Status changed from recruiting to completed.
- 18 Jul 2017 Planned End Date changed from 1 Oct 2016 to 1 Oct 2019.
- 18 Jul 2017 Planned primary completion date changed from 1 Aug 2016 to 1 Oct 2019.